Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

Yu-Tzu Tai, Ph.D., Michel de Weers, Ph.D., Xian-Feng Li, MS, Weihua Song, MD, Sabikun Nahar, B.S., Joost M Bakker, Tom Vink, Daniëlle Jacobs, Lukas Oomen, Wim K Bleeker, Nikhil C. Munshi, MD, Jan G. J. van de Winkel, PhD, Paul W. H. I. Parren, PhD, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD

Blood (2009) 114 (22): 608.

https://doi.org/10.1182/blood.V114.22.608.608

Published: 2009

Journal Articles

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

Yu-Tzu Tai, Ph.D., Umesh Muchhal, Ph.D., Xian-Feng Li, MS, Sabikun Nahar, B.S., Weihua Song, MD, Holly Horton, Ph.D, Hanh Nguyen, Sher Karki, John Desjarlais, Nikhil C. Munshi, MD, Paul Richardson, M.D., Ph.D., Kenneth C. Anderson, MD

Blood (2009) 114 (22): 609.

https://doi.org/10.1182/blood.V114.22.609.609

Published: 2009

Journal Articles

Halofuginone, an Old Anticoccidosis Drug, Induces Apoptosisin Multiple Myeloma Cells, Associated with Down Regulation of MCL1.

Merav Leiba, MD, Yu-Tzu Tai, PHD, Teru Hideshima, MD, PHD, Jana Jakubikova, PHD, Ikeda Hiroshi, MD, PHD, Xian-Feng Li, MS, Peter Burger, BS, Paul Richardson, MD, Nikhil C. Munshi, MD, Arnon Nagler, MD, Kenneth C. Anderson, MD

Blood (2007) 110 (11): 4786.

https://doi.org/10.1182/blood.V110.11.4786.4786

Published: 2007

Journal Articles

CD27-Mediated Apoptosis Is Dependent on Siva-Induced Caspase Activation in Human Multiple Myeloma.

Yu-Tzu Tai, PhD, Xian-Feng Li, MS, Rory Coffey, BS, Iris Breitkreutz, MD, Laurence Catley, MBBS FRACP FRCPA, Robert L. Schlossman, MD, Paul G. Richardson, MD, Nikhil C. Munshi, MD, Steven P. Treon, MD, PhD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 3398.

https://doi.org/10.1182/blood.V106.11.3398.3398

Published: 2005

Journal Articles

Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40-Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications.

Yu-Tzu Tai, PhD, Laurence Catley, MD, Xian-Feng Li, MS, Rory Coffey, BS, Iris Breitkreutz, MD, Jooeun Bae, PhD, Klaus Podar, MD, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Robert Schlossman, MD, Paul Richardson, MD, Steven P. Treon, MD, PhD, Iqbal S. Grewal2, PhD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 5150.

https://doi.org/10.1182/blood.V106.11.5150.5150

Published: 2005

Journal Articles

Role of BAFF in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment.

Yu-Tzu Tai, PhD, Xian-Feng Li, MS, Rory Coffey, BS, Iris Breitkreutz, MD, Laurence Catley Laurence Catley, MBBS, FRACP, FRCPA, Klaus Podar, MD, PhD, Teru Hideshima, MD, PhD, Dharminder Chauhan, PhD, Noopur Raje, MD, Robert Schlossman, MD, Paul Richardson, MD, Nikhil C. Munshi, MD, Kenneth C. Anderson, MD

Blood (2005) 106 (11): 627.

https://doi.org/10.1182/blood.V106.11.627.627

Published: 2005

Journal Articles

Chromosomal Deletions and Amplifications in Multiple Myeloma Detected by 500K Single Nucleotide Polymorphism Array Analysis.

Yu-Tzu Tai, PhD, Cheng Li, PhD, Rory Coffey, BS, Iris Breitkreutz, MD, Xian-Feng Li, MS, Laurence Laurence Catley, MBBS FRACP FRCPA, Robert L. Schlossman, MD, Paul G. Richardson, MD, Kenneth C. Anderson, MD, Nikhil C. Munshi, MD

Blood (2005) 106 (11): 1551.

https://doi.org/10.1182/blood.V106.11.1551.1551

Published: 2005

NARROW

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

Halofuginone, an Old Anticoccidosis Drug, Induces Apoptosisin Multiple Myeloma Cells, Associated with Down Regulation of MCL1.

CD27-Mediated Apoptosis Is Dependent on Siva-Induced Caspase Activation in Human Multiple Myeloma.

Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40-Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications.

Role of BAFF in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment.

Chromosomal Deletions and Amplifications in Multiple Myeloma Detected by 500K Single Nucleotide Polymorphism Array Analysis.

Email alerts

ASH Publications

American Society of Hematology

Daratumumab, a Novel Potent Human Anti-CD38 Monoclonal Antibody, Induces Significant Killing of Human Multiple Myeloma Cells: Therapeutic Implication.

XmAb®5592 Fc-Engineered Humanized Anti-HM1.24 Monoclonal Antibody Has Potent in Vitro and In Vivo Efficacy against Multiple Myeloma.

Halofuginone, an Old Anticoccidosis Drug, Induces Apoptosisin Multiple Myeloma Cells, Associated with Down Regulation of MCL1.

CD27-Mediated Apoptosis Is Dependent on Siva-Induced Caspase Activation in Human Multiple Myeloma.

Immunomodulatory Drug Lenalidomide (CC-5013, IMiD3) Augments Anti-CD40 SGN-40-Induced Cytotoxicity in Human Multiple Myeloma: Clinical Implications.

Role of BAFF in Adhesion and Growth of Human Multiple Myeloma Cells in the Bone Marrow Microenvironment.

Chromosomal Deletions and Amplifications in Multiple Myeloma Detected by 500K Single Nucleotide Polymorphism Array Analysis.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only